A Windber doctor is set to lead a global organization at the forefront of a rapidly advancing field that is critical to personalized medicine.

Chinese scientists are celebrating a new breakthrough cancer drug, but some Chinese citizens are skeptical of domestically ...

The widespread use of antibiotics in industrial animal agriculture is contributing to the rise of antibiotic resistance, with ...

LONDON, UK — Vatican officials have said Pope Francis has developed pneumonia in both lungs, further complicating his ...

Fidji Simo rose from a village childhood to Meta executive, taking Instacart public as CEO, and OpenAI board post. She shares ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

“Double pneumonia” is not an official medical term. It may be being used to describe two different aspects of Pope Francis’s ...